Work

Immunobiology and Metabolic Pathways of Renal Cell Carcinoma

Year: 2023

Type: review

Source: Hematology/Oncology Clinics of North America

DOI: 10.1016/j.hoc.2023.04.012

Authors: David A. Braun, Abhishek A. Chakraborty

Institutions: Yale Cancer Center, Yale University, Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland Clinic Research, Case Western Reserve University

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: AstraZeneca United States, U.S. Department of Defense, American Cancer Society, V Foundation for Cancer Research, American Chemical Society, American Society of Clinical Oncology, AbbVie, Cleveland Clinic, Cleveland Clinic Foundation, Exelixis, Yale Cancer Center, National Comprehensive Cancer Network, Aptitude Health, National Institutes of Health, National Cancer Institute

Awards: G1192669028, G2172368230, G247240440, UNDERSTANDING CD8+ T-CELL SPECIFICITY AND FUNCTION IN RENAL CELL CARCINOMA, EXPLOITING EPIGENETIC DYSREGULATION TO IDENTIFY TARGETABLE VULNERABILITIES IN CCRCC, Cancer Center Support Grant

OpenAlex ID: W4378364358

FWCI: 0.185

Cites: 89

Cited by: 4

Related to: 10